Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Trinity Medical Group (OTC BB:TMGU.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Location
30021 Tomas Street, Suite 300
RSM, CA 92688
Phone: (949) 459-2170
Fax: (949) 459-2163
Email: gwilson@trinitymg.com
Employees (last reported count): 4
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 72%
·Institutional: 0% (1% of float)
(one institution)
·Net Inst. Buying: 25.0K shares (+49.97%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Trinity Medical Group USA, Inc., an affiliate of Trinity Medical Group, Ltd., a Thailand company, is a late development stage company with rights to market an HIV-Immunogen known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus (HIV). REMUNE is an immune-based therapy consisting of whole, inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology.
More from Market Guide: Expanded Business Description

Financial Summary
Trinity Medical Group is a late development stage company with rights to market a patented therapeutic vaccine known as REMUNE, which is designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus (HIV). For the six months ended 6/30/01, the Company reported no revenue. Net loss totaled $2.1 million, up from $449 thousand. Results reflect higher research and development expenses and an increase in SG&A expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Arun Churdboonchart, 59
Chairman
--  
James Namnath, 44
CEO, Director
$268K
Vina Churdboonchart, 55
Pres, Director
--  
Gary Wilson, 34
CFO, Exec. VP-Fin., Treasurer
194K
Elizabeth Namnath, 49
Sec.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:TMGU.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$0.50 
Recent Price$2.06 
52-Week High
on 25-May-2001
$5.59 
Daily Volume (3-month avg)24.7K
Daily Volume (10-day avg)16.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
13-Week Change+19.8%
13-Week Change
relative to S&P500
+33.2%
Share-Related Items
Market Capitalization$23.9M
Shares Outstanding11.6M
Float3.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.16 
Earnings (ttm)-$0.35 
Earnings (mrq)-$0.13 
SalesN/A 
Cash (mrq)$0.04 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$2.91M
Income available to common (ttm)-$3.82M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-2177.88%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.21 
Debt/EquityN/A 
Total Cash (mrq)$502.0K
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.